Jump to content

Ceftizoxime

From Wikipedia, the free encyclopedia
Ceftizoxime
Clinical data
Trade namesCefizox
AHFS/DrugsConsumer Drug Information
MedlinePlusa684043
ATC code
Identifiers
  • (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.210.846Edit this at Wikidata
Chemical and physical data
FormulaC13H13N5O5S2
Molar mass383.40g·mol−1

Ceftizoximeis a third-generationcephalosporinavailable forparenteral administration.[1] Unlike other third-generation cephalosporins, the whole C-3 side chain in ceftizoxime has been removed to preventdeactivationbyhydrolytic enzymes. It rather resemblescefotaximein its properties, but is not subject tometabolism.It was removed from the US Market in 2007.

Synthesis

[edit]

Injectable third generation cephalosporin antibiotic related tocefotaxime,q.v.Exhibits broad spectrum activity and resistance to β-lactamase hydrolysis.

Ceftizoxime synthesis:[2][3]

References

[edit]
  1. ^Aldridge KE (1990). "An update on the in vitro activity of ceftizoxime and other cephalosporin/cephamycin antimicrobial agents against clinically significant anaerobic bacteria".Clinical Therapeutics.12 Suppl C: 3–12.PMID2202509.
  2. ^DE 2810922,Takaya T, Hisashi T, Kiyoshi T, Toshiyuki C, "New cepham compounds and processes for the production thereof", issued 29 August 1985, assigned toFujisawa
  3. ^US 4427674,Takaya T, Hisashi T, Kiyoshi T, Toshiyuki C, "Cephem compounds", issued 24 January 1984, assigned toFujisawa